Clinical Trials Sponsored by Alydia Health

Total 50254 results

Alydia Health

Completed

Feasibility Clinical Investigation Using the InPress Device for the Treatment of Postpartum Hemorrhage

Post Partum Hemorrhage

Indonesia
Alydia Health

Completed

Safety and Effectiveness of the Jada System in Treating Primary Postpartum Hemorrhage (PEARLE)

Postpartum Hemorrhage

United States
Alydia Health

Completed

RUBY Post-Market Registry on the Jada® System (RUBY)

Postpartum Hemorrhage

United States
Acadia University
Lallemand Health Solutions

Unknown

Effects of a Probiotic Supplement on Symptoms of Attention Deficit Hyperactivity Disorder and Anxiety in Children

Anxiety | Attention Deficit Hyperactivity Disorder

Canada
Avidia

Unknown

Phase 1 Study of Safety and Biological Effects of C326, an Inhibitor of IL-6, in Crohn's Disease

Crohn's Disease

Australia
Isabel Andia

Active, not recruiting

Greater Trochanteric Pain Syndrome: Efficacy of Ultrasound Guided Platelet-rich Plasma vs Needle Tenotomy. (PRP-GTPS)

Tendinopathy

Spain
Alaxia SAS

Terminated

Dose Escalation Study of ALX-009 in Healthy Men and Cystic Fibrosis (CF) and Non-CF Bronchiectasis Patients

Bronchiectasis | Cystic Fibrosis

France
Amydis Inc.

Recruiting

A Study of AMDX-2011P in Participants With Primary Open Angle Glaucoma

Primary Open Angle Glaucoma

United States
Amydis Inc.

Recruiting

AMDX-2011P Retinal Tracer in Subjects With Neurodegenerative Diseases Associated With Amyloidogenic Proteinopathy (PROBE)

Parkinson Disease | Amyotrophic Lateral Sclerosis

United States
Alaxia SAS

Recruiting

Dose Finding Study of STR-324

Pain, Acute

Netherlands
Acadia University

Unknown

Probiotics and the Microbiome: Clinical Intervention Trial for Anxiety and Depression

Depression | Anxiety

Canada
Aydin Maternity and Child Health Hospital

Enrolling by invitation

Tricuspid Annular Plane Systolic Excursion to Predict Arterial Hypotension Caused by Spinal Anesthesia in Caesarean Section (CESERAN TAPSE)

Hypotension

Turkey
Aydin Maternity and Child Health Hospital

Enrolling by invitation

Investigating Maternal Effects of Positions Applied in Patients Preparing for Caesarean Section Under Spinal Anesthesia (cs position)

Hypotension

Turkey
Aydin Maternity and Child Health Hospital

Recruiting

The Relationship of Preoperative Fasting With Tricuspid Annular Plane Systolic Movement in Female Patients (FASTİNGTAPSE)

TAPSE

Turkey
Lydia Nabil

Completed

Comparison of Double Y-shaped Plates and Lag Screws in Fixation of Anterior Mandibular Fractures

Mandibular Fractures

Egypt
Lydia Nabil

Completed

Evaluation of a Combined Ridge Expansion Technique With Simultaneous Dental Implant Placement

Alveolar Process Atrophy

Egypt
Lydia Nabil

Completed

Comparison of Two Pre-prosthetic Surgical Techniques for Augmentation of Mandibular Vertical Ridge Defects

Alveolar Ridge Enlargement

Egypt
ACADIA Pharmaceuticals Inc.

Recruiting

Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome

Hyperphagia in Prader-Willi Syndrome

United States, Canada
ACADIA Pharmaceuticals Inc.

Recruiting

Pimavanserin for the Treatment of Irritability Associated With Autism Spectrum Disorder

Irritability Associated With Autism Spectrum Disorder

United States, Spain, France, Australia, Poland, Italy, Hungary
ACADIA Pharmaceuticals Inc.

Completed

Open-Label Extension Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome (LILAC™)

Rett Syndrome

United States
ACADIA Pharmaceuticals Inc.

Active, not recruiting

Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE-2)

Schizophrenia

Argentina, Bulgaria, Croatia, Czechia, Hungary, Italy, Lithuania, Poland, Russian Federation, Serbia, Spain, Ukraine
ACADIA Pharmaceuticals Inc.

Completed

Open-Label Extension Study of Trofinetide for Rett Syndrome

Rett Syndrome

United States
ACADIA Pharmaceuticals Inc.

Completed

Open-Label Study With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease Psychosis

Parkinson Disease Psychosis

United States
ACADIA Pharmaceuticals Inc.

Completed

A Safety Study of Pimavanserin in Adult and Elderly Subjects Experiencing Neuropsychiatric Symptoms Related to Neurodegenerative Disease

Neuropsychiatric Symptoms Related to Neurodegenerative Disease

United States, Russian Federation, Serbia, Poland, Georgia, Czechia, Bulgaria, Colombia, Mexico, Romania, South Africa, Ukraine
ACADIA Pharmaceuticals Inc.

Terminated

Study to Evaluate Safety and Daytime Sedation in Subjects With Parkinson's Disease With Neuropsychiatric Symptoms Treated With Pimavanserin or Low-Dose Quetiapine

Parkinson's Disease

United States
ACADIA Pharmaceuticals Inc.

Terminated

The INSYTE (Management of Parkinson's Disease Psychosis in Actual Practice) Study

Parkinson Disease Psychosis

United States
ACADIA Pharmaceuticals Inc.

Completed

Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis

Dementia-related Psychosis

United States, Spain, Poland, Ukraine, Chile, Czechia, United Kingdom, Bulgaria, France, Germany, Italy, Serbia, Slovakia
ACADIA Pharmaceuticals Inc.

Completed

Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE)

Schizophrenia

United States, Spain, Hungary, Bulgaria, Russian Federation, Serbia, Ukraine, Poland, Canada, Czechia
ACADIA Pharmaceuticals Inc.

Completed

A Study of Pimavanserin for the Treatment of Agitation and Aggression in Subjects With Alzheimer's Disease

Agitation and Aggression in Alzheimer's Disease

United States, Spain, Chile, France, United Kingdom
ACADIA Pharmaceuticals Inc.

Completed

Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder (CLARITY)

Adjunctive Treatment of Major Depressive Disorder

United States
ACADIA Pharmaceuticals Inc.

Terminated

Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease (SERENE)

Agitation and Aggression in Alzheimer's Disease

United States, France, Spain, Chile, United Kingdom
ACADIA Pharmaceuticals Inc.

Completed

A Study of the Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis

Parkinson's Disease Psychosis

France, United States, Bulgaria, Russian Federation, United Kingdom, Ukraine, India
ACADIA Pharmaceuticals Inc.

Completed

ACP-104 in Acutely Psychotic Subjects With Schizophrenia

Schizophrenia

United States
ACADIA Pharmaceuticals Inc.

Recruiting

ACP-204 in Adults With Alzheimer's Disease Psychosis

Alzheimer's Disease Psychosis

United States
ACADIA Pharmaceuticals Inc.

Recruiting

Extension Study of Pimavanserin in Irritability Associated With Autism Spectrum Disorder

Irritability Associated With Autism Spectrum Disorder

United States, Spain, France, Hungary, Poland, Italy
ACADIA Pharmaceuticals Inc.

Completed

Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome (LAVENDER™)

Rett Syndrome

United States
ACADIA Pharmaceuticals Inc.

Completed

Extension Study of Pimavanserin in Adult Subjects With Neuropsychiatric Symptoms Related to Neurodegenerative Disease

Neuropsychiatric Symptoms Related to Neurodegenerative Disease

Serbia, United States, Poland, Georgia, Russian Federation, Bulgaria, Colombia, Czechia, Mexico, Romania, South Africa, Ukraine
ACADIA Pharmaceuticals Inc.

Completed

Evaluate the Efficacy and Safety of ACP-044 for the Treatment of Acute Postoperative Pain Following Bunionectomy

Acute Postoperative Pain | Bunionectomy

United States
ACADIA Pharmaceuticals Inc.

Terminated

Evaluate the Efficacy and Safety of ACP-044 in Subjects With Pain Associated With Osteoarthritis of the Knee

Osteoarthritis Pain

United States
ACADIA Pharmaceuticals Inc.

Completed

A Study of the Safety and Efficacy of Pimavanserin in Patients With Alzheimer's Disease Psychosis

Alzheimer's Disease Psychosis

United Kingdom
ACADIA Pharmaceuticals Inc.

Completed

A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis

Parkinson's Disease Psychosis

Spain, United States, Belgium, Austria, Serbia, Poland, Portugal, Italy, Sweden
ACADIA Pharmaceuticals Inc.

Approved for marketing

Expanded Access of Pimavanserin for Patients With PD Psychosis

Parkinson's Disease Psychosis
ACADIA Pharmaceuticals Inc.

Completed

A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis

Parkinson's Disease Psychosis

United States, Canada
ACADIA Pharmaceuticals Inc.

Not yet recruiting

ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study

Alzheimer's Disease Psychosis

United States
Asylia Diagnostics BV

Recruiting

Open-label, Uncontrolled, Non-Interventional, Retrospective Study to Evaluate Molecular Determinants of Outcome to the Immune Checkpoint Inhibitors (Anti-PD-1/Anti-PD-L1 Monoclonal Antibodies) Treatment for Solid Tumors

Melanoma | Lung Cancer

Belgium
ACADIA Pharmaceuticals Inc.

Recruiting

Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia

Schizophrenia

Lithuania, Canada, Ukraine, Argentina, Bulgaria, Croatia, Czechia, Hungary, Italy, Poland, Russian Federation, Serbia, Spain, United States
ACADIA Pharmaceuticals Inc.

Completed

An Open-Label Study of Trofinetide for the Treatment of Girls Two to Five Years of Age Who Have Rett Syndrome (DAFFODIL™)

Rett Syndrome

United States
ACADIA Pharmaceuticals Inc.

Terminated

Extension Study of Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment

Adjunctive Treatment of Major Depressive Disorder

United States, Serbia, Finland, Poland, Russian Federation, Slovakia, South Africa, Ukraine, United Kingdom
ACADIA Pharmaceuticals Inc.

Completed

Adjunctive Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment

Adjunctive Treatment of Major Depressive Disorder

United States, Serbia, Finland, Poland, Russian Federation, Ukraine, United Kingdom, Slovakia, South Africa
ACADIA Pharmaceuticals Inc.

Completed

An Open-label Safety Study of Pimavanserin in Parkinson's Disease Patients

Parkinson's Disease Psychosis

United States

Clinical Trials Sponsored by Alydia Health

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malawi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations